Premium
Genetic alterations of the Cdx2 gene in gastric cancer
Author(s) -
SONG JAE HWI,
KIM CHANG JAE,
CHO YONG GU,
CHAE HIUN SUK,
CAO ZHANG,
NAM SUK WOO,
LEE JUNG YOUNG,
PARK WON SANG
Publication year - 2008
Publication title -
apmis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0903-4641
DOI - 10.1111/j.1600-0463.2008.00881.x
Subject(s) - cdx2 , intestinal metaplasia , biology , missense mutation , cancer research , exon , cancer , carcinogenesis , gastric mucosa , mutation , gene , genetics , stomach , gene expression , homeobox , biochemistry
Gastric atrophy and intestinal metaplasia are generally considered precancerous lesions of the stomach; Cdx2 plays an important role in intestinal metaplasia and gastric carcinogenesis. To elucidate the potential etiological role of the Cdx2 gene in gastric carcinogenesis, we analyzed genetic mutations and allelic loss in the Cdx2 gene of 95 sporadic gastric cancers. We found two somatic missense mutations in the Cdx2 gene, P63L in exon 1 and E204K in exon 2, encoding the caudal‐like protein activation region (codon 13–180) and the homeobox domain (codon 188–243) of the gene, in the gastric cancers. In addition, 9 (25.0%) of 36 informative cases showed allelic loss at D13S220 and/or D13S260. In 11 cases with a genetic alteration, Cdx2 nuclear staining was observed only in 8 cases of gastric mucosa with intestinal metaplasia. Loss or reduced expression of the Cdx2 gene in cancer cells was found in two cases with a somatic mutation and in three cases with LOH. Interestingly, all of the cases were intestinal‐type gastric cancers. Thus, these results suggest that genetic alterations of the Cdx2 gene may contribute to the loss of Cdx2 expression and to the development of gastric cancer, especially in the intestinal‐type.